Korea Laennec® Liver Function Improvement Injection

    Korea Laennec

      01 What is Laennec? Where is the only legally authorized place of use in China?

      Laennec is an injectable preparation of human placental hydrolysate. It has decades of clinical application history outside China and is widely used in Japan, South Korea, and other regions. It is a prescription-only medical preparation and is by no means a health supplement or a cosmetic injectable. The preparation has not been marketed nationwide in China. Under the "special licensed drugs and devices, early and pilot implementation" policy of the Boao Lecheng International Medical Tourism Pilot Zone, it was officially approved for use in Lecheng in September 2024. It is centrally controlled and fully traceable through the Lecheng Central Pharmacy and may be used compliantly only at designated hospitals. At present, the only legitimate channel in China is use at designated medical institutions in Boao Lecheng (such as Shulan Boao Hospital and Boao Super Hospital) after in-person consultation and assessment.

      02 What liver conditions can it be used for?

      According to public disclosures by the Hainan Provincial Medical Products Administration and the official Lecheng pharmacy:

      ✅ The only approved indication in China: improvement of liver function in chronic liver disease.

      Within the scope of clinical education, chronic liver disease includes a variety of common liver injury conditions, which are also the main patient scenarios for which Laennec is considered suitable in hospital doctors' assessments:

      - Abnormal liver function caused by various types of chronic hepatitis

      - Liver injury and abnormal transaminase levels caused by fatty liver and alcoholic liver disease

      - Drug-induced decline in liver function and decline caused by long-term sleep deprivation and overwork

      - Functional conditioning for people with liver fibrosis and those in the recovery phase of chronic liver injury

      - In clinical practice, Laennec can serve as an adjunctive means of comprehensive management of chronic liver disease, focusing on repairing damaged liver cells, improving liver function status, and helping stabilize liver metabolic function.

      03 Extended clinical applications outside China

      Based on decades of clinical research literature outside China, in overseas clinical applications Laennec has been used not only for liver function conditioning but also in various scenarios of physical function conditioning, while also receiving subjective feedback from users:

      - Conditioning of physical status in people with chronic fatigue and metabolic disorders

      - Adjunctive maintenance for people with immune imbalance and frequent fatigue and weakness

      - Some users have reported mild improvements in physical condition and skin condition

      The above scenarios are not included in the approved indications under the Boao Lecheng special licensing approval. They are provided only as popular-science content based on overseas clinical literature and should not be used as a basis for medication or conditioning in China. Related subjective effects vary from person to person, are not universally applicable, and no efficacy commitments or promotional claims are made.

      04 Compliant use process at Boao Lecheng

      To ensure medication safety, Boao Lecheng has a strict standardized process for the use of Laennec, which is also currently the only compliant use pathway in China: 1. The person visits a designated medical institution in Boao Lecheng in person; 2. Liver function and basic physical examinations are completed, and a professional doctor comprehensively assesses the person's physical condition; 3. After assessment confirms eligibility, an informed consent form is signed and the drug is used in a standardized manner within the hospital; 4. For people who meet the Lecheng special drug management regulations, the drug may be applied for and taken out of the hospital compliantly in accordance with official policy. The entire process involves hospital record-keeping, full drug traceability, and doctor-controlled oversight throughout, fundamentally eliminating safety issues such as counterfeit drugs and non-compliant operations.

      05 Reference for suitable populations

      Based on the official indications and clinical conditioning value, the following groups may pay particular attention to the adjunctive conditioning role of this specially licensed preparation:

      - People with chronic liver injury due to long-term sleep deprivation, frequent alcohol consumption, and irregular daily routines

      - People with fatty liver or chronic hepatitis who need long-term adjunctive conditioning of liver function

      - People taking medication long-term whose liver bears a heavy metabolic burden and whose liver function is relatively weak

      - People with long-term physical fatigue and weakness and poor metabolic status who need comprehensive maintenance and conditioning

      06 Disclaimer

      This article is only a popular-science sharing of Boao Lecheng specially licensed drugs and devices. It does not constitute any diagnostic or treatment advice, medication promotion, or efficacy commitment. Laennec is an imported specially licensed prescription injectable preparation from outside China, and in China it may be professionally consulted, assessed, and used compliantly only at designated medical institutions in Boao Lecheng. The diseases and physical scenarios mentioned in this article are merely examples for popular-science purposes. This product is only used for adjunctive conditioning to improve liver function in chronic liver disease and does not replace standard clinical treatment. All medication, conditioning plans, and suitability determinations are subject to the assessment conclusions of practicing doctors within Lecheng hospitals.

Herun International Medical Center, Herun International Preventive Medicine Center, Herun Medical